Three Arch Partners
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as
Business Model:
Revenue: $7.3M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Three Arch Partners Information
Geographic Data
Address: 3200 Alpine Rd
City: Portola Valley
State: CA
Zip: 94028
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Contact Phone:
+16505298000
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2008 | Novasys Health | Venture Round | 49.5M |
| 1/2008 | Benvenue Medical | Series B | 15M |
| 11/2003 | Cameron Health | Series B | 29M |
| 5/2008 | Novasys Medical, Inc. | Series D | 49.5M |
| 10/2005 | Cameron Health | Series C | 15M |
| 7/2006 | Cameron Health | Series D | 31M |
| 11/2006 | Concert Pharmaceuticals | Series B | 48.5M |
| 4/2006 | Concuity | Series E | 2.5M |
| 11/2012 | MEI Pharma | Post-IPO Equity | 27.5M |
| 7/2003 | VisionCare Ophthalmic Technologies | Series B | 6.8M |
| 1/2004 | NeuroVista | Series A | 7.3M |
| 8/2003 | LipoScience | Series E | 15M |
| 11/2002 | Coalescent Surgical | Series D | 0 |
| 3/2007 | SquareOne | Series C | 0 |
| 6/2002 | Novare Surgical | Series C | 9.8M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 5/2007 | Arete Therapeutics | Series A | 35M |
| 6/2011 | Crux Biomedical | Series C | 12M |
| 11/2003 | VisionCare Ophthalmic Technologies | Series C | 12.4M |
| 7/2007 | Satiety | Series D | 30M |
| 12/2004 | NeuroBionics | Series A | 6M |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 3/2006 | Reliant Technologies | Series D | 22M |
| 5/2007 | NeuroVista | Series B | 33.8M |
| 8/2002 | Concuity | Series C | 16.3M |
| 10/2009 | Neuronetics | Series D | 0 |
| 8/2006 | Neuronetics | Series C | 0 |
| 8/2010 | Respicardia | Series C | 0 |
| 10/2012 | Access Closure | Venture Round | 0 |
| 10/2011 | Salveo Specialty Pharmacy | Series A | - |
| 4/2003 | iScience Interventional | Series C | 15M |
| 3/2007 | Calistoga Pharmaceuticals | Series A | 21M |
| 6/2010 | Calistoga Pharmaceuticals | Series C | 40M |
| 9/2004 | Vascular Architects | Series E | 0 |
| 1/2008 | Calistoga Pharmaceuticals | Series A | 5.2M |
| 9/2004 | Allux Medical | Series A | 800k |
| 8/2000 | Epocrates | Series B | 35M |
| 12/2005 | Oculir | Series A | 7.3M |
| 8/2002 | Epocrates | Series C | - |
| 8/2002 | Threshold Pharmaceuticals | Series A | 8.3M |
| 1/2012 | Access Closure | Venture Round | 0 |
| 2/2007 | Visiogen | Venture Round | 24M |
| 4/2007 | iScience Interventional | Series E | 20M |
| 10/2010 | TriReme Medical | Series D | 17M |
| 1/2002 | Opus Medical | Series B | 2.1M |
| 5/2009 | Calistoga Pharmaceuticals | Series B | 30M |
| 1/2005 | Reliant Technologies | Series C | 7M |
| 11/2011 | Inova Labs | Series B | 0 |
| 2/2004 | Reliant Technologies | Series B | 12.9M |
| 6/1997 | Spinal Dynamics | Series A | - |
| 7/2002 | Visiogen | Series B | 5M |
| 11/2009 | Calibra Medical | Venture Round | 1.4M |
| 1/2004 | Threshold Pharmaceuticals | Series B | 41M |
| 7/2002 | Opus Medical | Series B | 6.5M |
| 6/2003 | Opus Medical | Series C | 13.6M |
| 1/2011 | VisionCare Ophthalmic Technologies | Series E | 0 |
| 3/2011 | Tibion Bionic Technologies | Series B | 0 |
| 11/2007 | SquareOne | Series C | 8M |
| 3/2005 | Confluent Surgical | Series D | 0 |
| 7/2008 | Eleme Medical | Series C | 0 |
| 1/2003 | Vascular Architects | Series D | 0 |
| 3/2004 | Coalescent Surgical | Series E | 2M |
| 8/2006 | LipoScience | Series F | 13M |
| 4/2007 | Aspen MedTech | Venture Round | 1M |
| 7/2004 | LipoSonix | Series C | 27M |
| 5/2009 | iScience Interventional | Series F | 20.5M |
| 2/2009 | SpinalMotion | Venture Round | 500k |
| 1/2008 | Arbor Surgical Technologies | Series C | 0 |
| 5/2007 | Pegasus Biologics | Series C | 20M |
| 3/2005 | Sirtris Pharmaceuticals | Series B | 27M |
| 4/2006 | Sirtris Pharmaceuticals | Series C | 37M |
| 3/2005 | iScience Surgical | Series C | 0 |
| 3/2007 | SmoothShapes | Series B | 15M |
| 10/2004 | Concuity | Venture Round | 8.3M |
| 10/2007 | TriReme Medical | Series C | 15.5M |
| 3/2005 | SpinalMotion | Series B | 20.1M |
| 7/2002 | Transvascular | Series D | 10.8M |
| 8/2008 | Calibra Medical | Series B | 35M |
| 9/2008 | Baxano | Series B | 20M |
| 3/2010 | Access Closure | Venture Round | 10M |
| 6/2002 | Spiration | Series D | 22M |
| 3/2005 | Neuronetics | Series B | 8.5M |
| 12/2006 | Respicardia | Series A | 5.5M |
| 6/2005 | Pegasus Biologics | Series B | 10M |
| 10/2005 | Radiant Medical | Venture Round | 36M |
| 12/2006 | NBI Development | Seed Round | 5.5M |
| 4/2010 | Hemosphere | Series A | 9.3M |
| 6/2010 | Voyage Medical | Series C | 20.6M |
| 8/2008 | Voyage Medical | Series B | 22M |
| 1/2008 | North American Scientific | Venture Round | 15.5M |
| 7/2004 | Vitra Bioscience | Venture Round | 5.5M |
| 9/2006 | Calibra Medical | Series A | 8.6M |
| 3/2007 | Ascend Health | Series B | 20.1M |
| 1/2012 | iScience Interventional | Venture Round | 2.8M |
| 6/2010 | Baxano | Series C | 30M |
| 3/2008 | Spiration | Series G | 18.5M |
| 1/2001 | Phylos | Series B | 25M |
| 7/2010 | Ingenuity Systems | Venture Round | 15.4M |
| 11/2003 | The Center from Health Promotion | Venture Round | 10M |
| 7/2011 | Nevro | Series B | 58M |
| 12/2006 | Nevro | Seed Round | 5.5M |
| 9/2008 | Nevro | Series A | 21.8M |
| 6/2017 | Neuronetics | Series G | 0 |
| 1/2010 | Free &a; Clear | Venture Round | 10M |
| 4/2015 | Neuronetics | Series F | 0 |
| 5/2011 | Neuronetics | Series E | 30M |
| 7/2006 | Concert Pharmaceuticals | Series A | 10M |
| 4/2008 | Concert Pharmaceuticals | Series C | 0 |
| 9/2008 | APT Pharmaceuticals | Series B | 32M |
| 4/2006 | Spiration | Series F | 13.4M |
| 10/2008 | Respicardia | Series B | 0 |
| 6/2008 | Cameron Health | Series E | 0 |
| 5/2004 | Evalve | Series C | 0 |
| 3/2013 | Nevro | Series C | 0 |
| 1/2004 | Spiration | Series E | 0 |
| 3/2002 | Novacept | Venture Round | 30M |
| 3/2000 | MEDCHANNEL | Series B | 42M |
| 12/2003 | Visiogen | Venture Round | 16.5M |
| 1/2007 | AcuFocus | Series D | 0 |
| 12/2002 | VetCentric | Venture Round | 14.5M |
| 11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
| 1/2005 | VisionCare Ophthalmic Technologies | Series D | 20M |
| 4/2007 | Reliant Technologies | Series E | 15M |
| 4/2005 | Allux Medical | Series B | 5M |
| 5/2009 | Visiogen | Series D | 40M |
| 6/2017 | Neuronetics | Series G | 0 |
| 4/2015 | Neuronetics | Series F | 0 |
| 11/2013 | Ocera Therapeutics | Post-IPO Equity | 0 |
| 3/2013 | Nevro | Series C | 0 |
| 11/2012 | MEI Pharma | Post-IPO Equity | 0 |
| 10/2012 | Access Closure | Venture Round | 0 |
| 1/2012 | iScience Interventional | Venture Round | 0 |
| 1/2012 | Access Closure | Venture Round | 0 |
| 11/2011 | Inova Labs | Series B | 0 |
| 10/2011 | Salveo Specialty Pharmacy | Series A | - |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
